Enjoy complimentary customisation on priority with our Enterprise License!
The statin market size is forecast to increase by USD 2.62 billion at a CAGR of 3.2% between 2023 and 2028. The market is experiencing significant growth due to the rising prevalence of hypercholesterolemia and the strong incidence of coronary heart disease (CHD). Chronic diseases, such as diabetes, and acute conditions, including respiratory problems, continue to increase the demand for statins. Additionally, statins are essential for managing cholesterol levels in heart transplant recipients and cardiac transplant patients undergoing heart valve surgery. The market growth is driven by the stringent regulatory environment, which ensures the safety and efficacy of statin medications. In the US, the Centers for Disease Control and Prevention (CDC) reports that approximately 95 million adults have high cholesterol, making it a significant public health concern. This trend is expected to continue, leading to increased demand for statins in the coming years.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.